ProfileOfResearchers

Identified 2

1

TITLE: Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
AUTHORS: Emmanuel Bachy; John F Seymour; Pierre Feugier; Fritz Offner; Armando Lopez Guillermo; David Belada; Luc Xerri; John V Catalano; Pauline Brice; Francois Lemonnier; Alejandro Martin; Olivier Casasnovas; Lars M Pedersen; Veronique Dorvaux; David Simpson; Sirpa Leppa; Jean Gabarre; Maria G da Silva; Sylvie Glaisner; Loic Ysebaert; Anne Vekhoff; Tanin Intragumtornchai; Steven Le Gouill; Andrew Lister; Jane A Estell; Gustavo Milone; Anne Sonet; Jonathan Farhi; Harald Zeuner; Herve Tilly; Gilles Salles; ...More
PUBLISHED: 2019, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, ISSUE: 31

INDEXED IN:

Scopus

WOS

2

TITLE: Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial Full Text
AUTHORS: Gilles Salles; John Francis Seymour; Fritz Offner; Armando Lopez Guillermo; David Belada; Luc Xerri; Pierre Feugier; Reda Bouabdallah; John Vincent Catalano; Pauline Brice; Dolores Caballero; Corinne Haioun; Lars Moller Pedersen; Alain Delmer; David Simpson; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; Christophe Ferme; Maria Gomes da Silva; Catherine Sebban; Andrew Lister; Jane A Estell; Gustavo Milone; Anne Sonet; Myriam Mendila; Bertrand Coiffier; Herve Tilly; ...More
PUBLISHED: 2011, SOURCE: LANCET, VOLUME: 377, ISSUE: 9759

INDEXED IN:

Scopus

WOS

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service